BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2724416)

  • 1. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.
    Bray M; Zhao BT; Markoff L; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1989 Jun; 63(6):2853-6. PubMed ID: 2724416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.
    Falgout B; Bray M; Schlesinger JJ; Lai CJ
    J Virol; 1990 Sep; 64(9):4356-63. PubMed ID: 2143542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
    Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus premembrane and membrane proteins elicit a protective immune response.
    Bray M; Lai CJ
    Virology; 1991 Nov; 185(1):505-8. PubMed ID: 1926792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus.
    Zhao BT; Prince G; Horswood R; Eckels K; Summers P; Chanock R; Lai CJ
    J Virol; 1987 Dec; 61(12):4019-22. PubMed ID: 3316711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.
    Fonseca BA; Pincus S; Shope RE; Paoletti E; Mason PW
    Vaccine; 1994; 12(3):279-85. PubMed ID: 8165861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.
    Eckels KH; Dubois DR; Summers PL; Schlesinger JJ; Shelly M; Cohen S; Zhang YM; Lai CJ; Kurane I; Rothman A
    Am J Trop Med Hyg; 1994 Apr; 50(4):472-8. PubMed ID: 8166355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a.
    Falgout B; Chanock R; Lai CJ
    J Virol; 1989 May; 63(5):1852-60. PubMed ID: 2522997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.
    Konishi E; Pincus S; Fonseca BA; Shope RE; Paoletti E; Mason PW
    Virology; 1991 Nov; 185(1):401-10. PubMed ID: 1833876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue.
    Deubel V; Kinney RM; Esposito JJ; Cropp CB; Vorndam AV; Monath TP; Trent DW
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1921-9. PubMed ID: 3404119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.
    Srivastava AK; Putnak JR; Warren RL; Hoke CH
    Vaccine; 1995 Sep; 13(13):1251-8. PubMed ID: 8578812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge.
    Men R; Wyatt L; Tokimatsu I; Arakaki S; Shameem G; Elkins R; Chanock R; Moss B; Lai CJ
    Vaccine; 2000 Jul; 18(27):3113-22. PubMed ID: 10856791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice.
    Delenda C; Staropoli I; Frenkiel MP; CabaniƩ L; Deubel V
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1569-78. PubMed ID: 8021588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
    Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein.
    Parrish CR; Woo WS; Wright PJ
    Arch Virol; 1991; 117(3-4):279-86. PubMed ID: 1826827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.
    Fleeton MN; Sheahan BJ; Gould EA; Atkins GJ; Liljestr M P
    J Gen Virol; 1999 May; 80 ( Pt 5)():1189-1198. PubMed ID: 10355766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.
    Men RH; Bray M; Lai CJ
    J Virol; 1991 Mar; 65(3):1400-7. PubMed ID: 1995950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.